Let's discuss your project
Our AI-powered solutions offer unprecedented quantitative data into the morphology of lipid nanoparticles. Cryo-EM offers observable results, something impossible with indirect methods like Dynamic Light Scattering (DLS). This combination enables robust formulation and forced degradation studies.
Benefit from our unique, high-throughput cryo-EM platform, and discern challenging epitopes in 3D. With the possibilities of cryo-EM, you can screen several FAB/mAbs in complex with your target to visualize conformations, contacting residues, and binding locations.
We provide control over the cryo-EM 3D structure determination process. With our cutting-edge cryo-EM facility, computational resources, and 50+ years of collective expertise, we optimize and de-risk project budget. Our unique biochemical sample optimization assays enhance project success rates.
Cryo-EM revolutionizes AAV characterization in gene therapy R&D, offering precise analysis of critical quality attributes. It enables unparalleled identification of full, empty, and intermediate AAV particles across various serotypes, enhancing quality assurance and therapeutic efficacy.
ATEM is a specialist cryo-EM CRO working exclusively in biologics, LNPs, AAV vectors & antibody programs.
Unlike generalist providers, we deliver decision-ready answers to the specific question blocking your next developtment milestones.
Our workflows are engineered around the client’s program timeline. Fit-for-purpose scoping means clients are not paying for analysis beyond what their question requires.
We work exclusively in biologics. That exclusivity is not a limitation, it is the source of the precision that generalist providers cannot match.
Every engagement ends with a panel-ready, decision-ready answer to the specific question your discovery campaign brought.
Our team of experts is the backbone of our GMP-certified operations, which enables us to deliver outputs that withstand both regulatory scrutiny and scientific peer review.
You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information
